Ziten 20 mg (Teneligliptin)

Product Overview

Ziten 20 mg is a prescription oral medication developed by Glenmark Pharmaceuticals Ltd. It belongs to the class of dipeptidyl peptidase‑4 (DPP‑4) inhibitors and is indicated for the management of type 2 diabetes mellitus. According to the National Institutes of Health, DPP‑4 inhibitors are a class of antidiabetic agents. The product is supplied in a strip containing 15 tablets, each strength 20 mg of the active ingredient teneligliptin. Pack sizes of 30, 60, and 90 tablets are available to support chronic therapy. Delivery typically takes 6 to 15 days from the time of order. This medication is intended for patients who require additional glycemic control alongside diet and exercise, and it may be used in combination with metformin, sulfonylureas, or insulin when appropriate.

What is Ziten 20 mg

Ziten 20 mg contains teneligliptin, a selective DPP‑4 inhibitor that enhances the activity of incretin hormones such as GLP‑1 and GIP. By blocking the DPP‑4 enzyme, teneligliptin prolongs the lifespan of these hormones, leading to increased insulin secretion from pancreatic beta cells and reduced glucagon release after meals. The drug is marketed under the brand name Ziten and is manufactured by Glenmark Pharmaceuticals Ltd., a company with a global footprint in generic and specialty pharmaceuticals. The formulation is film‑coated to protect the tablet from gastric acid and to ensure consistent release of the active ingredient.

Uses and Benefits

The primary use of Ziten 20 mg is to improve glycemic control in adults with type 2 diabetes who have not achieved target HbA1c levels with diet and exercise alone. Clinical studies have demonstrated that teneligliptin reduces fasting plasma glucose and post‑prandial glucose excursions with a low risk of hypoglycemia when used as monotherapy or in combination with other oral agents. Patients often experience a modest weight‑neutral effect, which is advantageous compared with some sulfonylureas that can promote weight gain. Additionally, the once‑daily dosing schedule supports adherence, and the medication does not require dose adjustments for mild to moderate hepatic impairment.

How It Works

Teneligliptin functions by inhibiting the enzyme dipeptidyl peptidase‑4, which rapidly degrades incretin hormones. When DPP‑4 is blocked, GLP‑1 and GIP remain active for a longer period, enhancing glucose‑dependent insulin secretion and suppressing glucagon release. This mechanism results in a glucose‑lowering effect that is proportional to the current blood glucose concentration, thereby minimizing the risk of excessive lowering. The drug’s half‑life is approximately 12 hours, allowing for once‑daily administration. Pharmacokinetic data indicate that food does not significantly affect absorption, making it convenient to take with or without meals.

Dosage Guidelines

The recommended starting dose of Ziten 20 mg is one tablet taken orally once daily, preferably at the same time each day. The dose may be adjusted based on renal function; patients with severe renal impairment (creatinine clearance <30 mL/min) should use a reduced dose of 10 mg once daily, although teneligliptin is not officially approved for end‑stage renal disease. The tablet should be swallowed whole with water and does not need to be taken with food. If a dose is missed, the patient should take it as soon as remembered unless it is close to the time of the next scheduled dose, in which case the missed dose should be skipped. Consistency in dosing helps maintain steady plasma concentrations and optimal glycemic control.

Side Effects

The most commonly reported side effects include nasopharyngitis, urinary tract infection, and mild hypoglycemia when combined with other glucose‑lowering agents. Less frequent but clinically significant events may involve pancreatitis, severe allergic reactions, and liver enzyme elevations. For detailed drug information, see the Drugs.com entry on teneligliptin. Patients should be advised to report persistent abdominal pain, vomiting, or signs of allergic reaction such as rash or swelling immediately. In rare cases, teneligliptin has been associated with acute kidney injury, particularly in patients with pre‑existing renal disease or those using concomitant nephrotoxic drugs. Regular monitoring of renal function is recommended during long‑term therapy.

Warnings and Precautions

Before initiating treatment with Ziten 20 mg, healthcare providers should assess patients for a history of pancreatitis, severe renal impairment, or hypersensitivity to teneligliptin. Caution is advised in patients with a history of heart failure or those taking medications that may increase the risk of hypoglycemia. The drug should be used with care in pregnant or lactating women only if the potential benefit justifies the potential risk, and animal studies have not shown teratogenicity at therapeutic exposures. Patients should be instructed to maintain adequate hydration and to avoid excessive alcohol consumption, which may exacerbate the risk of hypoglycemia. Routine laboratory monitoring, including renal function tests and liver enzymes, is recommended at intervals determined by the prescribing clinician.

Frequently Asked Questions

Q: Can Ziten 20 mg be taken with other diabetes medications?
A: Yes, it can be used in combination with metformin, sulfonylureas, or insulin, but dosage adjustments may be necessary to avoid hypoglycemia.

Q: How long does it take to see a reduction in blood glucose levels?
A: Improvements in glycemic control are typically observed within 1–2 weeks of consistent use, though individual response may vary.

Q: Is dose adjustment needed for elderly patients?
A: No specific dose adjustment is required based on age alone; however, clinicians should consider renal function, which often declines with age.

Q: What should I do if I experience severe abdominal pain?
A: Stop the medication and seek medical attention promptly, as this could be a sign of pancreatitis.

Q: Are there any dietary restrictions while taking Ziten 20 mg?
A: No specific dietary restrictions are required; the medication can be taken with or without food.

Related Products

• Tazret Gel 0.05% (Tazarotene)
• Tazret Forte Cream (Tazarotene)
• Apremilast 30 mg (Generic)
• Aprezo 30 mg (Apremilast)
• Tazarotene Gel 0.05% (Generic)
• Tazarotene Cream (Generic)
• Flucort Cream (Fluocinolone)
• Flucort Cream 20gm (Fluocinolone)
• Flucort N Cream (Fluocinolone/Neomycin)
• Flucort C Cream (Fluocinolone/Ciclopirox)
• Flucort H Cream (Fluocinolone)
• Halovate Cream (Halobetasol)